Wat is de prijs voor SQZ Biotechnologies Company (SQZ)

Het prijs van SQZ Biotechnologies Company (SQZ) is $0.05083

Wat is de marktkapitalisatie voor SQZ Biotechnologies Company (SQZ)

Marktkapitalisatie voorSQZ Biotechnologies Company (SQZ) is $732.57K

SQZ Biotechnologies Company (SQZ) Prijsgeschiedenis

SQZ Biotechnologies, a biotechnology firm currently in the clinical development phase, is focused on creating cell-based therapies for various severe ailments, including cancerous growths, autoimmune disorders, and infectious diseases. Its primary experimental therapeutic, known as SQZ-PBMC-HPV, is derived from its SQZ Antigen Presenting Cells technology. This treatment is currently undergoing Phase I clinical trials, both as a standalone therapy and alongside other immune-oncology treatments, to address advanced or metastatic solid tumors positive for HPV16, encompassing cancers of the cervix, head-and-neck, anus, penis, vulva, and vagina. Furthermore, the company is progressing with SQZ-AAC-HPV, another Phase I clinical candidate targeting the same HPV16+ advanced or metastatic solid tumors, which is also being evaluated as a single agent and in conjunction with other immune-modulating agents. Beyond these, SQZ Biotechnologies is also advancing its SQZ Activating Antigen Carriers and SQZ Tolerizing Antigen Carriers platforms. Established in 2013, the company operates from its main office in Watertown, Massachusetts.

Jaar	Prestaties
2023	-94.93%
2022	-90.40%
2021	-61.01%
2020	0.00%

Jaar

Prestaties

2023

-94.93%

2022

-90.40%

2021

-61.01%

2020

0.00%

Bedrijf	Aandelenkoers	Verandering 1jr%	Land
Vertex Pharmaceuticals Incorporated VRTX.US	$504.83	29.34%	US
Argenx SE ARGX.US	$839.07	28.61%	NL
Lonza Group AG LONN.SW	$728.83	6.71%	CH
Samsung Biologics Co.,Ltd. 207940.KS	$1.07K	-6.40%	KR
UCB S.A. UCB.BR	$252.06	11.35%	BE

Bedrijf

Aandelenkoers

Verandering 1jr%

Land